American Lung Association Announces Lung Health Experts to Serve as National Volunteer Media Spokespeople
Editors: Please note local interest.
(July 7, 2016) - CHICAGO
For more information please contact:
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease. Serving as the premier resource for lung health, the Lung Association today announced it has launched its first-ever national volunteer media spokesperson program.
"From lung cancer and asthma to healthy air and e-cigarettes, the public deserves lung health information they can trust," said American Lung Association National President and CEO Harold P. Wimmer. "We are proud to announce that we will be formalizing a nationwide volunteer network of lung health experts to share trusted lung health information with the public and news media."
For the 2016-2017 fiscal year, six lung health experts have been appointed to one-year terms as American Lung Association media spokespeople:
- Brian W. Christman, MD, Nashville, Tenn., is Professor of Medicine and Associate Program Director for the Vanderbilt University Internal Medicine Residency Program and former Director of the Fellowship Program in Pulmonary and Critical Care Medicine at Vanderbilt. Christman serves veterans as Chief of Medical Service at the VA Tennessee Valley Healthcare System. With expertise in pulmonary hypertension, critical care, asthma and healthy air, Christman has published more than 100 journal articles and book chapters and serves on the American Lung Association Scientific Advisory Committee.
- Jorge Gomez, MD, New York, N.Y., is a medical oncologist who specializes in the treatment of patients with lung cancer. He is the Medical Director of the Thoracic Oncology Program and the World Trade Center oncology clinic at Mount Sinai Hospital in New York City. He started his lung cancer career as a member of the Thoracic Oncology Program at Memorial Sloan-Kettering Cancer Center, followed by five years with the Thoracic Oncology Program at the University of Miami. He dedicates his time to clinical research and patient care. His primary research interests are the therapeutics of lung cancer including immunotherapy and targeted therapies, and has participated in multiple clinical trials with novel drugs.
- MeiLan King Han, MD, MS, Ann Arbor, Mich., is an Associate Professor of Internal Medicine in the Division of Pulmonary and Critical Care Medicine at the University of Michigan Health System and Director of the Women's Respiratory Clinic. Her expertise includes end stage lung diseases including chronic obstructive pulmonary disease (COPD), interstitial lung disease and lymphangioleiomyomatosis. She also serves as the Principal Investigator at the University of Michigan for two large NHLBI-funded COPD cohort studies as well as the American Lung Association Airways Clinical Research Centers (ACRC) Network.
- Andrea McKee, MD, Boston, Mass., is a partner at Radiation Oncology Associates, PA, and currently serves as Chairman of Radiation Oncology at the Lahey Hospital & Medical Center, Sophia Gordon Cancer Center in Burlington, MA, and Lahey Medical Center Peabody, in Peabody, MA. Dr. McKee has co-authored numerous seminal peer-reviewed publications on the design, implementation and management of clinical CT lung screening programs and was an invited advisor to the Centers for Medicare & Medicaid Services during the development of the current national CT lung cancer screening guidelines.
- Daniel S. Oh, MD, Los Angeles, Calif., is Assistant Professor of Surgery at the Keck School of Medicine at the University of Southern California and Director of the Center for Thoracic Diseases at St. Jude Medical Center in Orange County, California. Dr. Oh specializes in general thoracic surgery, and has an interest in applying and expanding the role of minimally invasive and robotic technology in both diagnosis and treatment. Dr. Oh is an integral part of the multidisciplinary USC/Norris and St. Jude Lung Cancer Program, and his primary research interest is to apply the genetic information of thoracic tumors to personalize patient therapy. Dr. Oh has also served as a member and board chair of the American Lung Association in Los Angeles leadership board.
- Deepika Polineni, MD, MPH, Kansas City, Kansas, is Assistant Professor of Internal Medicine in the Division of Pulmonary and Critical Care Medicine at the University of Kansas Medical Center. She serves as the Associate Adult Program Director for the University of Kansas Cystic Fibrosis Care Center, and Director for the University of Kansas and Children's Mercy Hospital Primary Ciliary Dyskinesia Clinical Center. Her research interests include the identification of non-CFTR genetic modifiers of cystic fibrosis (CF) lung disease, as well as developing methods for improving treatment adherence in CF. She serves as a member of the American Lung Association Scientific Peer Review Committee.
For media interested in scheduling an interview or speaking with an American Lung Association National Volunteer Media Spokesperson about lung health, healthy air, lung cancer, tobacco use and tobacco policies and more, contact Media@Lung.org or 312-801-7628.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.